Annual Cash & Cash Equivalents
$1.07 M
-$1.29 M-54.67%
31 December 2023
Summary:
Yield10 Bioscience annual cash & cash equivalents is currently $1.07 million, with the most recent change of -$1.29 million (-54.67%) on 31 December 2023. During the last 3 years, it has fallen by -$2.35 million (-68.80%). YTEN annual cash & cash equivalents is now -95.92% below its all-time high of $26.19 million, reached on 31 December 2008.YTEN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$733.00 K
-$864.00 K-54.10%
30 June 2024
Summary:
Yield10 Bioscience quarterly cash and cash equivalents is currently $733.00 thousand, with the most recent change of -$864.00 thousand (-54.10%) on 30 June 2024. Over the past year, it has dropped by -$2.08 million (-73.98%). YTEN quarterly cash and cash equivalents is now -97.94% below its all-time high of $35.66 million, reached on 31 March 2008.YTEN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.7% | -74.0% |
| 3 y3 years | -68.8% | -95.0% |
| 5 y5 years | -64.7% | -74.5% |
YTEN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -80.0% | at low | -95.0% | at low |
| 5 y | 5 years | -80.3% | at low | -96.1% | at low |
| alltime | all time | -95.9% | at low | -97.9% | +7.0% |
Yield10 Bioscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $733.00 K(-54.1%) |
| Mar 2024 | - | $1.60 M(+49.5%) |
| Dec 2023 | $1.07 M(-54.7%) | $1.07 M(-62.1%) |
| Sept 2023 | - | $2.82 M(+20.6%) |
| June 2023 | - | $2.34 M(+29.1%) |
| Mar 2023 | - | $1.81 M(-23.2%) |
| Dec 2022 | $2.36 M(-55.8%) | $2.36 M(-39.9%) |
| Sept 2022 | - | $3.92 M(+23.3%) |
| June 2022 | - | $3.18 M(+49.4%) |
| Mar 2022 | - | $2.13 M(-60.1%) |
| Dec 2021 | $5.33 M(+55.7%) | $5.33 M(-63.5%) |
| Sept 2021 | - | $14.62 M(-6.5%) |
| June 2021 | - | $15.64 M(-15.8%) |
| Mar 2021 | - | $18.58 M(+442.9%) |
| Dec 2020 | $3.42 M(-36.8%) | $3.42 M(+14.3%) |
| Sept 2020 | - | $3.00 M(-9.0%) |
| June 2020 | - | $3.29 M(-23.4%) |
| Mar 2020 | - | $4.29 M(-20.7%) |
| Dec 2019 | $5.42 M(+79.2%) | $5.42 M(+88.3%) |
| Sept 2019 | - | $2.88 M(-11.5%) |
| June 2019 | - | $3.25 M(-46.4%) |
| Mar 2019 | - | $6.07 M(+100.6%) |
| Dec 2018 | $3.02 M(-79.1%) | $3.02 M(-8.6%) |
| Sept 2018 | - | $3.31 M(+4.4%) |
| June 2018 | - | $3.17 M(-58.2%) |
| Mar 2018 | - | $7.58 M(-47.7%) |
| Dec 2017 | $14.49 M(+98.2%) | $14.49 M(+390.9%) |
| Sept 2017 | - | $2.95 M(-2.0%) |
| June 2017 | - | $3.01 M(-38.2%) |
| Mar 2017 | - | $4.88 M(-33.3%) |
| Dec 2016 | $7.31 M(-40.4%) | $7.31 M(-25.3%) |
| Sept 2016 | - | $9.78 M(+163.8%) |
| June 2016 | - | $3.71 M(-29.7%) |
| Mar 2016 | - | $5.27 M(-57.0%) |
| Dec 2015 | $12.27 M(-38.8%) | $12.27 M(-31.4%) |
| Sept 2015 | - | $17.89 M(-21.2%) |
| June 2015 | - | $22.71 M(+71.3%) |
| Mar 2015 | - | $13.26 M(-33.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $20.05 M(+160.4%) | $20.05 M(-21.3%) |
| Sept 2014 | - | $25.49 M(+360.8%) |
| June 2014 | - | $5.53 M(+53.4%) |
| Mar 2014 | - | $3.61 M(-53.2%) |
| Dec 2013 | $7.70 M(-47.2%) | $7.70 M(-13.2%) |
| Sept 2013 | - | $8.87 M(-25.5%) |
| June 2013 | - | $11.91 M(-41.9%) |
| Mar 2013 | - | $20.51 M(+40.8%) |
| Dec 2012 | $14.57 M(-31.5%) | $14.57 M(-16.3%) |
| Sept 2012 | - | $17.41 M(+43.5%) |
| June 2012 | - | $12.13 M(+26.3%) |
| Mar 2012 | - | $9.60 M(-54.9%) |
| Dec 2011 | $21.28 M(+69.9%) | $21.28 M(+22.3%) |
| Sept 2011 | - | $17.39 M(-12.1%) |
| June 2011 | - | $19.78 M(-1.3%) |
| Mar 2011 | - | $20.05 M(+60.0%) |
| Dec 2010 | $12.53 M(+15.8%) | $12.53 M(-13.2%) |
| Sept 2010 | - | $14.43 M(+1.9%) |
| June 2010 | - | $14.17 M(+2.6%) |
| Mar 2010 | - | $13.80 M(+27.6%) |
| Dec 2009 | $10.81 M(-58.7%) | $10.81 M(+10.6%) |
| Sept 2009 | - | $9.78 M(+4.9%) |
| June 2009 | - | $9.31 M(-30.5%) |
| Mar 2009 | - | $13.39 M(-48.9%) |
| Dec 2008 | $26.19 M(+15.5%) | $26.19 M(-4.0%) |
| Sept 2008 | - | $27.29 M(+23.5%) |
| June 2008 | - | $22.10 M(-38.0%) |
| Mar 2008 | - | $35.66 M(+57.2%) |
| Dec 2007 | $22.69 M(-9.9%) | $22.69 M(+9.6%) |
| Sept 2007 | - | $20.70 M(+129.2%) |
| June 2007 | - | $9.03 M(-54.5%) |
| Mar 2007 | - | $19.86 M(-21.1%) |
| Dec 2006 | $25.18 M(+1272.3%) | $25.18 M(+307.1%) |
| Sept 2006 | - | $6.18 M(-59.4%) |
| June 2006 | - | $15.22 M(+2121.6%) |
| Mar 2006 | - | $685.30 K(-62.7%) |
| Dec 2005 | $1.83 M(-41.8%) | $1.83 M(-41.8%) |
| Dec 2004 | $3.15 M | $3.15 M |
FAQ
- What is Yield10 Bioscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Yield10 Bioscience?
- What is Yield10 Bioscience annual cash & cash equivalents year-on-year change?
- What is Yield10 Bioscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly cash and cash equivalents year-on-year change?
What is Yield10 Bioscience annual cash & cash equivalents?
The current annual cash & cash equivalents of YTEN is $1.07 M
What is the all time high annual cash & cash equivalents for Yield10 Bioscience?
Yield10 Bioscience all-time high annual cash & cash equivalents is $26.19 M
What is Yield10 Bioscience annual cash & cash equivalents year-on-year change?
Over the past year, YTEN annual cash & cash equivalents has changed by -$1.29 M (-54.67%)
What is Yield10 Bioscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of YTEN is $733.00 K
What is the all time high quarterly cash and cash equivalents for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly cash and cash equivalents is $35.66 M
What is Yield10 Bioscience quarterly cash and cash equivalents year-on-year change?
Over the past year, YTEN quarterly cash and cash equivalents has changed by -$2.08 M (-73.98%)